Clinical Evaluation of Pranada Gutika and Abhayarishta in the management of Arsha ( Haemorrhoids)

CCRAS0 个研究点目标入组 120 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients of either sex aged 16 â??60 years.
•2. Presence of 1st, 2nd& 3rd degree Arsha (Hemorrhoids) confirmed by clinical /proctoscopic / colonoscopic examination (With or without bleeding / painful or painless).
•3.Willing and able to participate in the study for 06 weeks

•1.Thrombosed&Strangulated pile mass (Hemorrhoids)
•2.Bleeding diathesis
•3.Cirrhosis of Liver- Portal hypertension
•4.Ulcerative colitis / Crohnâ??s disease
•5.Patients with evidence of malignancy
•6.Patients on prolonged ( > 6 weeks) medication with corticosteoids, antidepressants, anticholinergics, immunosuppressants, estrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study.
•7. Patients suffering from major systemic illness necessitating long term drug etc.
•8.Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, Stroke or Severe Arrhythmia in the last 6 months.
•9. Patients having uncontrolled Diabetes Mellitus (Blood Sugar Fasting > 120mg/dl).
•10. Pregnant/ lactating females.
•11. Patients on oral contraceptives.
•12. History of hypersensitivity to any of the trial drugs or their ingredients.
•13. Patients who have completed participation in any other clinical trial during the past six (06) months.
•14. Any other condition which the Investigator thinks may jeopardize the study.

发起方

CCRAS